Chaya Shwaartz, Nadav Zilka, Mustapha Siddiq, Yuri Goldes, MD. Sheba Medical Center, Israel
Background: D2 gastrectomy for gastric carcinoma is a well-established procedure in patients undergoing surgery for gastric cancer and is the standard of care in our institution. Reduced pain, early ambulation, and better cosmetics are some of the benefits of minimally invasive surgery for early gastric cancer. We aimed to describe our experience in laparoscopic D2 gastrectomies undertaken by a single surgeon in our institution.
Methods: This is a single-center retrospective review of prospectively collected D2 gastrectomies performed by a single surgeon. Between November 2011 and February 2017, 45 laparoscopic subtotal/total gastrectomies were performed at Sheba Medical Center, a tertiary center for forgut cancer. Clinicopathological characteristics of the patients, surgical performance, postoperative outcomes and pathological data were collected.
Results: Forty-five patients underwent laparoscopic gastrectomy. Of these, 38 had subtotal gastrectomy and 7 had total gastrectomy. The median age in our series 65 (43-89). Most of the patients in our series had early gastric cancer (T1-2) (80%). The mean average of dissected lymph nodes was 25 ± 13. The mean operative time was 249 ± 48. The postoperative complications, classified using the Clavien-Dindo classification. Severe complications (> CD IIIa) rate was 11%.
Conclusions: Laparoscopic D2 gastrectomy for invasive gastric cancer is safe and feasible when carried out in high-volume centers by an experienced surgeon as part of a multidisciplinary team with careful case selection and appropriate high-quality postoperative support.
Presented at the SAGES 2017 Annual Meeting in Houston, TX.
Abstract ID: 87365
Program Number: P411
Presentation Session: iPoster Session (Non CME)
Presentation Type: Poster